Dysregulation of key microRNAs in pancreatic cancer development - 09/12/18
pages | 8 |
Iconographies | 2 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
The most important miRNAs that are dysregulated in PC initiation and development via specific targets, which modulate cell cycle and proliferation, apoptosis, migration and invasion.
Highlights |
• | Pancreatic cancer is the fourth major cause of cancer-related death in the world. |
• | Dysregulation of some miRNAs have been related to the formation of pancreatic cancer. |
• | miRNAs modulate various steps of pancreatic cancer development and progression. |
• | miRNAs can use valuably for pancreatic cancer detection, prognosis and therapy. |
Abstract |
Pancreatic cancer (PC) is mentioned as one of the fourth major cause of cancer-related deaths and also is considered as one of the most malignancies worldwide. Sadly, widely metastasis is frequently observed at the time of PC detection and there are, thereby, almost poor prognosis and ineffective treatment in PC patients. microRNAs (miRNAs), a group of short non-coding RNAs, regulate various cellular and developmental mechanisms, such as cell growth, proliferation, apoptosis, differentiation and angiogenesis. Also, they have essential roles even on the progression of different human and animal diseases. In recent years, extensive studies confirmed the important role of miRNAs in various steps of PC developments, including; tumor initiation, invasion and metastasis, which can use valuably for cancer detection, prognosis and therapy. Therefore, the present study reviewed the new recent investigations in miRNAs involvement in the biology of PC associated with their clinical implications.
Le texte complet de cet article est disponible en PDF.Keywords : Pancreatic cancer, MicroRNA, Biomarker, Diagnosis, Dysregulation
Plan
Vol 109
P. 1008-1015 - janvier 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?